Multicenter Case Series of Pediatric Metformin Ingestion

Author:

Spiller Henry A1,Weber Julie A2,Winter Mark L3,Klein-Schwartz Wendy4,Hofman Maryann5,Gorman Susan E6,Stork Christine M7,Krenzelok Edward P8

Affiliation:

1. Henry A Spiller MS ABAT, Director, Kentucky Regional Poison Center of Kosair Children's Hospital, Louisville, KY

2. Julie A Weber BS CSPI, Education Coordinator, Cardinal Glennon Regional Poison Center, St. Louis, MO

3. Mark L Winter PhD ABAT, Specialist in Poison Information, Texas Poison Center Network, Galveston, TX

4. Wendy Klein-Schwartz PharmD MPH, Coordinator of Research and Education, Maryland Poison Center; Associate Professor, School of Pharmacy, University of Maryland, Baltimore, MD

5. Maryann Hofman BS CSPI, Specialist in Poison Information, The Poison Control Center, Philadelphia, PA

6. Susan E Gorman PharmD ABAT, Assistant Director, Georgia Poison Center, Atlanta, GA

7. Christine M Stork PharmD ABAT, Director, Central New York Poison Center, Syracuse, NY

8. Edward P Krenzelok PharmD ABAT, Director, Pittsburgh Poison Center; Professor, Schools of Pharmacy and Medicine, University of Pittsburgh, Pittsburgh, PA

Abstract

OBJECTIVE: There are no large studies, case series, or case reports of metformin ingestion in children. This study summarizes the clinical course and outcomes of metformin ingestion in children reported to the American Association of Poison Control Centers– Certified regional poison centers. METHODS: This was a case series of all metformin ingestions in patients <18 years of age reported to eight regional poison centers. Data collection included age, gender, dose ingested, co-ingestants, symptoms, vital signs, laboratory values, length of hospital stay, and medical outcome. Entrance into the study required at least 24 hours of follow-up. RESULTS: Fifty-five cases were collected. Ages ranged from 15 months to 17 years, with a mean (±SD) of 4.2 ± 4.4 years. The dose ingested, by history, ranged from 250 mg to 16.5 g, with a mean and median of 1710 ± 3391 and 500 mg, respectively. Forty-one children (76%) ingested a maximum of two tablets (=1700 mg). In the children younger than six years, dosage ranged from 9 to 196 mg/kg, with a mean and median of 60 ± 41.1 and 40 mg/kg, respectively. Thirty-seven children were evaluated in a healthcare facility. Clinical effects were limited to nausea (2), diarrhea (2), and dizziness (1). None of the 38 children who had serial glucose measurements experienced hypoglycemia. Arterial blood gas and electrolyte measurements were performed in three and 19 children, respectively. No evidence of acidosis was demonstrated. Two children had lactate concentrations measured and were determined to be in the normal range. Twenty-nine patients received activated charcoal. Five patients received parenteral glucose and one adolescent with a history of diabetes received insulin for hyperglycemia. CONCLUSIONS: Unintentional ingestion of ≤1700 mg of metformin in the healthy pediatric population does not appear to pose a significant health risk of hypoglycemia or detrimental outcome. In the 21 children who were tested for either blood glucose, electrolyte, or lactate concentrations, no evidence of lactic acidosis was seen.

Publisher

SAGE Publications

Subject

Pharmacology (medical)

Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3